Delivering End to End Biopharma Commercialization Value.
Altometrixs combines 25+ years of experience both as a manufacturer and principal consultant launching products and delivering business solutions across multiple therapeutic areas.
- Value Creation
- Value Delivery
- Value Maximisation
Delivering End to End Biopharma Commercialization Value.
Altometrixs combines 25+ years of experience both as a manufacturer and principal consultant launching products and delivering business solutions across multiple therapeutic areas.
- Value Creation
- Value Delivery
- Value Maximisation
Recognized Thought Leader
Value Maximization
Value Creation
Value Delivery
Discover the Altometrixs Value Impact Continuum
End to End Biopharma Commercial Value is realized through the unique blend of strategic and operational business experiences across multiple therapeutic launches, and helping multiple entities navigate complex market and business landscapes to achieve significant business results.
Value Maximization
Value Creation
Value Delivery
Discover the Altometrixs Value Impact Continuum
End to End Biopharma Commercial Value is realized through the unique blend of strategic and operational business experiences across multiple therapeutic launches, and helping multiple entities navigate complex market and business landscapes to achieve significant business results.
Value Creation
Strategic value is created through brand, patient
and multi-channel integration.
Value Delivery
Altometrixs strategic execution transforms implementation planning to actionable steps to ensure value is created and realized.
Value Maximization
Altometrixs maximizes value through optimizations and targeted growth and risk mitigations to drive biopharma business growth.
Value Creation
Strategic value is created through brand, patient and multi-channel integration.
Value Delivery
Altometrixs strategic execution transforms implementation planning to actionable steps to ensure value is created and realized.
Value Maximization
Altometrixs maximizes value through optimizations and targeted growth and risk mitigations to drive biopharma business growth.
BioPharma: Seamless Value, End to End
Altometrixs - Your Trusted Partner for Biopharma Commercialization
Trust is core principle of Altometrixs and leveraging its extensive experience creating and delivering BioPharma Value is best served as a trusted partner.
Altometrixs Value Impact Continuum
The Value Impact Continuum Approach Maximizes BioPharma Commercial Value from strategy development through Strategic Execution & Value Maximization. The core building blocks for Value Impact Continuum are integrally related.
- Value Creation
The magnitude of Value Creation is driven by the strategy development effectiveness and the integration into the various market access segments and channels.
- Value Delivery
Strategic execution drives the delivery of value. Elements of this are cross-functional implementation planning, defining success and measuring its attainment, and imparts accountability to key deliverables to name a few.
- Value Maximisation
Value maximization can be strategic and/or operational and is likely a function of current and emerging situations. Altometrixs as a trusted partner can help objectively assess and scope optimization and maximization opportunities, or help develop risk mitigation strategies.
Altometrixs Leverages Its Strategic Execution Expertise To Optimize Biopharma Commercialization Value
Altometrixs strategic execution approach maximizes biopharma commercialization value in and across multiple levels; patient, product, channel
Altometrixs Key Strategic Execution Components:
- Aligned and Integrated Channel, Distribution and Contracting Strategies
- Aligned and Rationalized Brand, Patient, Channel, and Customer Data Strategies to support …..
- Well Defined Key Performance Metrics (KPI) to transparently define success and …..
- Integrated and Aligned Data Strategies to Measure, Monitor and Manage Performance
Altometrixs Service Offerings Are Aligned Collaboratively
With Your Business Needs
Services are developed, implemented and realized Along Value Impact Continuum.
- Strategic Value Creation
- Product Launch
- DSA Portfolio Assessment
- DSA Strategy
- Aggregate Product Portfolio Assessments
- Integrated Launch Channel Strategies
- WH/SP/3PL Channel and Network Strategies
- DSA Design/Development
- DSA Financial Modeling
- Integrated Channel Contract Strategies
- Stakeholder/Channel Data Strategies
- Strategic Execution Services
- Integrated Launch Implementation Planning
- Contract Negotiation Strategies
- DSA Strategy
- Aggregate Product Portfolio Assessments
- Contract Development/Execution – WH/SD & SP
- Return Policy Development
- List 3PL Management/State Licensing
- KPI, Metrics and Dashboard Design
- Value Maximization & Optimization
- Sales & Operations Planning &S&OP
- Order to Cash
- Returns
- Channel & Inventory Mgt
- Chargebacks
- 3PL Management
- GTN Opportunities
- 34oB
- Returns
- Enterprise Contracting
- Inventory & Anomalies
Who we are?
Altometrixs Founder
Stephen Lagano, MS is an experienced healthcare business professional with extensive experience in the Biopharmaceutical industry. His unique combination of strategic and operations leadership and entrepreneurial experiences have consistently produced measurable end-to-end biopharma commercialization value. He has directly transformed organizations, executed multiple successful product launches and resolved a multitude of complex business situations.
He has consistently applied these skills to build and lead multiple “grass root” organizations ranging from Strategic Planning to Managed Market Segments to Order to Cash. His experiences across Managed Market Segments has provided deep expertise into the specialty and trade channels, customer business models & economics, multi-channel contracting, data strategies and advanced analytics.
His integration of these skills have been applied within and across Managed Markets to develop and implement brand, distribution, channel, and provider launch strategies across multiple therapeutic areas, managed market segments and wholesaler/specialty distribution channels. His end-to-end value is realized in operationalizing multiple business, customer, and channel strategies into measurable business results.
I had the pleasure of working with Steve for the past four years at Bayer. Steve's in-depth industry knowledge and experience coupled with a focus on delivering results is commendable. He collaboratively and diligently works developing short and long term multi-channel (trade and specialty) strategies integrating business insights and patient/customer perspectives into key decisions. I was impressed with his advanced business modeling and integration of work process flows to distill and simplify complex value propositions into integrated enterprise contracting strategies. We interacted frequently and he always shared the spotlight on collaborations when presented to leadership. He was and is a great mentor giving feedback and supporting areas for improvement. He is always a pleasure to be around with his thoughtful and engaging demeanor.
As US Brand Patient Marketing head, I led a time-sensitive & patient safety workstream to pivot our exclusively in-home Brand Patient Support Program, with the initial onset of Covid-19, towards a hybrid working model with both a remote & in-home exceptions option. The US Brand Team & I leaned heavy of Steve for his creativity, regulations insight & strategic commercial alignment to both patient & brand goals. While material program cost efficiencies were realized, this resulted without a loss in focus for patient-centric solutions. Thanks Steve for your valued contributions.
Steve has been a true asset to the legal team in our assessment of various Market Access proposals. He has complete command over FMV assessments, but more importantly Steve has tremendous knowledge and experience in the Pharma access and distribution space. He explains scenarios in a digestible, understandable manner and comes to the discussion prepared to answer and offer solutions for anticipated compliance questions. An excellent collaboration partner and a colleague I can confidently recommend.
Stephen Lagano and I have worked together in both client and supplier settings. Stephen possesses a sharp analytical mind and real-time knowledge of the pharmaceutical industry. His background as a professional engineer provides Stephen with a competitive advantage especially in business process & supply chain optimization. He also is an expert in operational planning, trade and specialty channel management. He is especially knowledgeable about managed markets, channel and contracting strategies and analytics. Stephen is the ultimate team player, ensuring that all stakeholders are engaged in framing business issues, planning and implementation. He communicates ongoing progress through multiple touch points and prior to completing assessments, pressure tests the results to ensure that they are actionable. Most importantly, Stephen is always approachable and ready to provide guidance. His cross-functional expertise always yields well-reasoned advice, listens genuinely and has a passion for building both the business and the careers of those who work with and for him. I never pass up an opportunity to speak with Stephen or collaborate with him on business issues.
"I've had the great opportunity to work with Altometrixs and Steve on a number of projects at Vertex Pharmaceuticals. From helping us develop our Specialty Pharmacy channel strategy, to FMV analyses, to advanced analytics across specialty pharmacies, patients, wholesalers, payers, etc to helping us automate our sales reporting system. Steve always delivered top-notch results along with an attitude and energy you wished all your colleagues had. I wouldn't hesitate to recommend Altometrixs and Steve for any commercial and/or managed markets projects because I know that he will bring insights and experiences that enable tremendous results."
Although I knew and interacted with Steve in more than one of his roles while our time at Roche overlapped, the basis of this endorsement is the period during which Steve was in charge of the corporate business planning process. Processes of this type must reflect multiple dimensions: larger corporate objectives, for example, must eventually translate into brand and operational plans. It is the nitty-gritty of real work. Local market realities and functional limits necessarily constrain the larger objectives. A dynamic and productive balance must exist between the creative and analytical effort that goes into a process versus the actual results the business needs to achieve to satisfy its corporate HQ and, ultimately, its owners. It isn’t easy. During his time in charge of redesigning and implementing this process, Steve brought both comprehensive approaches as well as iterative refinements. He interacted with a variety of stakeholders. He jettisoned that which no longer pertained. He incorporated new thinking, assessing and presenting aggregated information. All of these attributes led to our ability on the executive team to optimize better our financial and workforce resources. Steve brought both a highly personable nature and a great deal of real world, in the trenches experience to the process. Most important, Steve led the process as a means to an end rather than as an end in itself. As such, he was able to garner a higher quality of participation throughout the organization. He took the organization from business planning to realize operational planning at all levels.
Accelerate Your BioPharma Success: Partner with Altometrixs Now!
Collaborate with Altometrixs Today!
Altometrixs' Impact on Pharma & Biotech
With extensive experience in pharmaceutical and biotech industries, Altometrixs has supported companies in strategic planning, contracting, and process improvements. Browse our case studies to see the difference we’ve made for diverse organizations and the praise we’ve earned:
Case Studies
Blog posts
The latest news, technologies, and resources from our team.
Inventory Management – A Critical Leg in the “Three-Legged-Stool” of Demand Management
Demand management has different meanings to different audiences. For the sake of this discussion, demand management is defined as an understanding of […]
Do you need a strategic plan, a business plan or an operational plan?
Planning is a “personal” activity. Not everyone plans the same, some people are better planners than others and some are amazing at transitioning seamlessly across all types of planning. It is the “seamless” planner that knows what aspect of planning to emphasize when. Planning abilities aside, the important point is that everyone needs a plan; their needs vary so their plans vary. The important point that transcends all planners is you cannot successfully implement without a plan. Without some variation of plan how do you know where to start, how well you are doing and when are you done?
What Is Specialty Channel Management?
The specialty channels are driving both growth and channel complexity in the Pharma and Biotech industry. The specialty channels are more complex by design. Complexity = products handling requirements (e.g. cold chain), high prices (> $3K..), extensive patient support infrastructures/services, regulatory requirements (e.g. REMs), etc. Specialty channel management is like conventional channel management on steroids.
Benefit from Our Unique Multi-Therapeutic Expertise: Get in Touch!
Collaborating with Altometrixs accesses a wealth of expertise targeted to enhance your biopharma success. As our valued client, you’ll access to a diverse range of services rooted in our extensive experience with multiple drug launches across various therapeutic areas and business situations. Connect with Altometrixs to receive customized support that meets your business needs. Contact us today and discover how we can drive your success in this dynamic biopharma landscape.
Unlock Your BioPharma Potential
Don’t miss the chance to stay informed and connected in the fast-paced world of biopharma commercialization.
Ready for Altometrixs be Your Trusted Partner to Collaboratively Navigate BioPharma Complexities to Business Success
Understanding All the Biopharma Component Parts to Collectively Build Value
Leverage Altometrixs Execution Capabilities to Delivery And Optimize Value
Mining Knowledge Across Therapeutic Areas can Result in Insightful, Efficient and Synergistic Value
Connect with Altometrixs for Tangible Outcomes.